Abstract
Primary resistance mutations to fusion inhibitors and polymorphisms in gp41 sequences of non-B subtypes and recombinant HIV-1 isolates were analysed. L91H to RPR103611 was detected in one DGpol/Denv/Dgp41 recombinant; L9F and K144R, rarely reported previously, were frequent in the B region of CRF14_BG recombinants. V194I and V318A, not described in the G subtype, were detected in the G region of BG recombinants and in G subtype viruses that also show the rare mutations T115L, M118V and K90R.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / therapeutic use*
-
Drug Resistance, Viral / genetics*
-
Enfuvirtide
-
HIV Envelope Protein gp41 / genetics*
-
HIV Envelope Protein gp41 / therapeutic use
-
HIV Fusion Inhibitors / therapeutic use*
-
HIV Infections / genetics*
-
Humans
-
Male
-
Mutation / genetics*
-
Peptide Fragments / therapeutic use
-
Polymorphism, Genetic
Substances
-
Anti-HIV Agents
-
HIV Envelope Protein gp41
-
HIV Fusion Inhibitors
-
Peptide Fragments
-
Enfuvirtide